Initially, we were involved in contract manufacturing of pharmaceuticals and medicines, technology development, and as experts in the development of several pharmaceuticals and pharmaceutical products.
January 1st - Establishment of MEDITOP Pharmaceuticals Ltd.
Obtaining a pharmaceutical manufacturing licence for the production of solid dosage forms
Establishment of our own R&D department
Launch of the first non-prescription products (Mycosid, Betacid, Optacid, Hyperol)
First international partner (Novartis)
Registration of the first in house development prescription products.
Launch of Nasopax nasal spray, the company's first supergeneric product.
First international registration (Tolperisone in Germany).
Establishment of a representative office in Vietnam
Construction of a new factory and office complex - tripling the production area.
Purchase of brand new state-of-the-art equipment at a cost of around €6 million.
The most intensive international expansion in the company's history. Registration of more than 100 products in several countries in Europe and Asia.
Winner of the 2021 Hungarian Innovation Grand Prize.
New generic antiepileptic developed and registered in 6 EU countries. Obtain patent for manufacturing process.
Establishment of a Swiss subsidiary.
Opening of an Uzbek representative office.